291 related articles for article (PubMed ID: 22706088)
1. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.
Moorman JP; Wang JM; Zhang Y; Ji XJ; Ma CJ; Wu XY; Jia ZS; Wang KS; Yao ZQ
J Immunol; 2012 Jul; 189(2):755-66. PubMed ID: 22706088
[TBL] [Abstract][Full Text] [Related]
2. HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathway.
Ji XJ; Ma CJ; Wang JM; Wu XY; Niki T; Hirashima M; Moorman JP; Yao ZQ
Eur J Immunol; 2013 Feb; 43(2):458-67. PubMed ID: 23161469
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.
Franceschini D; Paroli M; Francavilla V; Videtta M; Morrone S; Labbadia G; Cerino A; Mondelli MU; Barnaba V
J Clin Invest; 2009 Mar; 119(3):551-64. PubMed ID: 19229109
[TBL] [Abstract][Full Text] [Related]
4. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
5. Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection.
Ebinuma H; Nakamoto N; Li Y; Price DA; Gostick E; Levine BL; Tobias J; Kwok WW; Chang KM
J Virol; 2008 May; 82(10):5043-53. PubMed ID: 18337568
[TBL] [Abstract][Full Text] [Related]
6. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
[TBL] [Abstract][Full Text] [Related]
7. Increased peripheral CD4
Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
[TBL] [Abstract][Full Text] [Related]
9. Tolerogenic dendritic cells induce CD4+CD25hiFoxp3+ regulatory T cell differentiation from CD4+CD25-/loFoxp3- effector T cells.
Huang H; Dawicki W; Zhang X; Town J; Gordon JR
J Immunol; 2010 Nov; 185(9):5003-10. PubMed ID: 20870943
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic IL-8 producing Foxp3⁺CD4⁺ regulatory T cells and fibrogenesis in chronic hepatitis C.
Langhans B; Krämer B; Louis M; Nischalke HD; Hüneburg R; Staratschek-Jox A; Odenthal M; Manekeller S; Schepke M; Kalff J; Fischer HP; Schultze JL; Spengler U
J Hepatol; 2013 Aug; 59(2):229-35. PubMed ID: 23624000
[TBL] [Abstract][Full Text] [Related]
11. Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis.
Itose I; Kanto T; Kakita N; Takebe S; Inoue M; Higashitani K; Miyazaki M; Miyatake H; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Viral Hepat; 2009 Dec; 16(12):844-52. PubMed ID: 19486278
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients.
Shen T; Zheng J; Liang H; Xu C; Chen X; Zhang T; Xu Q; Lu F
Virol J; 2011 Jun; 8():279. PubMed ID: 21645420
[TBL] [Abstract][Full Text] [Related]
13. Defining target antigens for CD25+ FOXP3 + IFN-gamma- regulatory T cells in chronic hepatitis C virus infection.
Li S; Jones KL; Woollard DJ; Dromey J; Paukovics G; Plebanski M; Gowans EJ
Immunol Cell Biol; 2007; 85(3):197-204. PubMed ID: 17199111
[TBL] [Abstract][Full Text] [Related]
14. PD-1 tempers Tregs in chronic HCV infection.
Radziewicz H; Dunham RM; Grakoui A
J Clin Invest; 2009 Mar; 119(3):450-3. PubMed ID: 19306502
[TBL] [Abstract][Full Text] [Related]
15. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
16. F protein increases CD4+CD25+ T cell population in patients with chronic hepatitis C.
Hashempour T; Bamdad T; Bergamini A; Lavergne JP; Haj-Sheykholeslami A; Brakier-Gingras L; Ajorloo M; Merat S
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25862675
[TBL] [Abstract][Full Text] [Related]
17. Expansion of FOXP3+ CD8 T cells with suppressive potential in colorectal mucosa following a pathogenic simian immunodeficiency virus infection correlates with diminished antiviral T cell response and viral control.
Nigam P; Velu V; Kannanganat S; Chennareddi L; Kwa S; Siddiqui M; Amara RR
J Immunol; 2010 Feb; 184(4):1690-701. PubMed ID: 20053943
[TBL] [Abstract][Full Text] [Related]
18. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
19. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.
Ren JP; Zhao J; Dai J; Griffin JW; Wang L; Wu XY; Morrison ZD; Li GY; El Gazzar M; Ning SB; Moorman JP; Yao ZQ
Immunology; 2016 Aug; 148(4):377-86. PubMed ID: 27149428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
